Johnson & Johnson Portfolio Holdings

Johnson & Johnson

  • $314 Million
  • Q3 2024

Johnson & Johnson has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $314 Million distributed in 20 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Protagonist Therapeutics, Inc with a value of $110M, Legend Biotech Corp with a value of $39.7M, Cv Rx, Inc. with a value of $36.2M, Nanobiotix S.A. with a value of $32.3M, and Procept Bio Robotics Corp with a value of $28.7M.

Examining the 13F form we can see an increase of $24.2M in the current position value, from $290M to 314M.

Johnson & Johnson is based out at New Brunswick, NJ

Below you can find more details about Johnson & Johnson portfolio as well as his latest detailed transactions.

Portfolio value $314 Million
Healthcare: $314 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$2.04B
$110 Million 35.09% of portfolio
2,449,183
Q3 2021 New
$5.71B
$39.7 Million 12.65% of portfolio
814,586
Q2 2023 Reduced 50.0%
$249M
$36.2 Million 11.52% of portfolio
4,103,430
Q1 2024 Added 17.39%
$108M
$32.3 Million 10.31% of portfolio
5,623,816
Q1 2024 Added 486.04%
$3.62B
$28.7 Million 9.14% of portfolio
357,939
Q4 2022 Reduced 58.57%
$277M
$27.7 Million 8.83% of portfolio
6,641,064
Q4 2022 Added 129.12%
$1.44B
$15 Million 4.8% of portfolio
748,062
Q4 2021 New
$163M
$11.8 Million 3.77% of portfolio
3,379,064
Q3 2021 New
$2.06B
$4.79 Million 1.53% of portfolio
247,598
Q3 2022 Reduced 80.36%
$30.5M
$4.25 Million 1.36% of portfolio
3,636,363
Q2 2024 New
$353M
$965,000 0.31% of portfolio
158,852
Q1 2024 Reduced 50.0%
$33.1M
$752,000 0.24% of portfolio
1,074,658
Q3 2021 New
$157M
$602,000 0.19% of portfolio
311,967
Q1 2024 New
$36.4M
$524,000 0.17% of portfolio
364,472
Q1 2024 Reduced 50.0%
$18.6M
$196,000 0.06% of portfolio
192,321
Q3 2024 Reduced 90.0%
$52.4M
$104,000 0.03% of portfolio
82,481
Q3 2024 New
Neumora Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q1 2024 Added 102.76%
Contineum Therapeutics Inc.
-
$0 0.0% of portfolio
-
Q2 2024 New
Rapport Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q2 2024 New

Summary

  • Portfolio
  • No. of Stocks 20
  • Current Value $314 Million
  • Prior Value $290 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 13, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Johnson & Johnson Portfolio

Follow Johnson & Johnson and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson & Johnson, based on Form 13F filings with the SEC.

News

Stay updated on Johnson & Johnson with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email